Cardiac surgery in cases of myeloproliferative neoplasm: risk factor for stroke
- 1 August 2012
- journal article
- research article
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 20 (4) , 398-403
Abstract
Objectives: a history of myeloproliferative neoplasms is considered to increase the risks in cardiac surgery. In patients with myeloproliferative neoplasms, increased rates of perioperative infections and thromboembolic complications are suspected, but studies analyzing the impact of myeloproliferative neoplasms on results after cardiac surgery are lacking. Methods: 13 patients with the diagnosis of myeloproliferative neoplasm underwent cardiac surgery. These patients were matched to 36 controls. Matching criteria consisted of sex, age, diagnosis, and comorbidities. Patients were analyzed regarding laboratory parameters, blood transfusion demands, morbidity, and mortality. Results: compared to controls, patients with myeloproliferative neoplasms demonstrated a significantly lower body-mass index (p < 0.01), creatinine (p = 0.024), prothrombin time (p = 0.001), and urea level (p = 0.012). The perioperative leukocyte response (p = 0.03) was ameliorated, and platelet counts (p < 0.02) increased. Patients with myeloproliferative neoplasms had a reduced need for erythrocyte concentrates (54% vs. 86%, p = 0.047) but increased need for plasma and thrombocytes (15% vs. 0%, p = 0.07). Patients with myeloproliferative neoplasms had a significantly increased incidence of thromboembolic events compared to controls (31% vs. 3%, p = 0.014). Hospital mortality remained at zero, but mid-term survival was lower in patients with myeloproliferative neoplasms (p = 0.078). Conclusions: myeloproliferative neoplasm as a concomitant diagnosis increases the risk of thromboembolic complications during cardiac surgery. Plasma and platelet substitutions have to be administered, although strokes were not associated with hemostatic treatment.Keywords
This publication has 11 references indexed in Scilit:
- Cardiac surgery and hematologic malignancies: a retrospective single-center analysis of 56 consecutive patientsEuropean Journal of Cardio-Thoracic Surgery, 2011
- Peripheral arterial ischemic events in cancer patientsVascular Medicine, 2010
- The 2008 World Health Organization classification system for myeloproliferative neoplasmsCancer, 2009
- Perioperative Monitoring of Primary and Secondary Hemostasis in Coronary Artery Bypass GraftingSeminars in Thrombosis and Hemostasis, 2005
- Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemiaBritish Journal of Haematology, 2005
- Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control studyThe Annals of Thoracic Surgery, 2002
- Chronische myeloproliferative SystemerkrankungenDer Pathologe, 2001
- Age and sex distributions of hematological malignancies in the U.K.Hematological Oncology, 1997
- Acquired von Willebrand Disease in Patients with High Platelet CountsSeminars in Thrombosis and Hemostasis, 1997
- Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 YearsAnnals of Internal Medicine, 1995